I don’t talk much about the value of bisantrene with those new to Race as it just drives away people - you have to have done a lot of research on your own before you understand the potential of what we have. What I tend to concentrate on is the low development risk due to the historical data and the discoveries we have made in drug delivery (reformulation) and best use (cardioprotection). I don’t talk much about FTO/m6A these days as it is too complex and blue sky.
I don’t talk much about the value of bisantrene with those new...
-
- There are more pages in this discussion • 730 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
